Alerts will be sent to your verified email
Verify Email
AKUMS
|
Akums Drugs & Pharma
|
Strides Pharma Scien
|
Medplus Health Serv.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
DMF Filingsby API
|
20.0 . | n/a | n/a |
|
R&D as a % of Total Sales
|
0.7 % | 1.84 % | n/a |
|
Financials
|
|||
|
5 yr Average ROE
|
6.41 % | 30.1 % | 6.33 % |
|
5yr average Equity Multiplier
|
3.41 | 2.62 | 1.94 |
|
5yr Average Asset Turnover Ratio
|
1.09 | 0.6 | 1.75 |
|
5yr Avg Net Profit Margin
|
1.94 % | 12.9 % | 1.86 % |
|
Price to Book
|
2.9 | 3.21 | 5.07 |
|
P/E
|
37.6 | 17.95 | 45.59 |
|
5yr Avg Cash Conversion Cycle
|
35.36 Days | -51.45 Days | 57.95 Days |
|
Inventory Days
|
61.49 Days | 69.05 Days | 80.0 Days |
|
Days Receivable
|
65.6 Days | 60.35 Days | 0.9 Days |
|
Days Payable
|
84.5 Days | 225.58 Days | 24.38 Days |
|
5yr Average Interest Coverage Ratio
|
1.96 | 0.72 | 2.1 |
|
5yr Avg ROCE
|
5.99 % | 10.5 % | 9.85 % |
|
5yr Avg Operating Profit Margin
|
6.33 % | 12.17 % | 7.22 % |
|
5 yr average Debt to Equity
|
0.41 | 1.01 | 0.06 |
|
5yr CAGR Net Profit
|
n/a | 68.01 % | 18.67 % |
|
5yr Average Return on Assets
|
1.61 % | 10.97 % | 3.23 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
75.26 % | 27.91 % | 40.22 % |
|
Share Pledged by Promoters
|
0.0 | 27.27 % | 60.74 % |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -0.36 % | -0.21 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
5.77 % | -2.58 % | 10.39 % |
|
Akums Drugs & Pharma
|
Strides Pharma Scien
|
Medplus Health Serv.
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
Operating Profit Break-Up
|
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
Asset Break-Up - Segment Wise
|
-
|